SignatureFD’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
Other funds holding KYMR
BBA
SignatureFD's KYMR Position: Q3 2026 in Review
SignatureFD increased its Kymera Therapeutics (KYMR) stake by 0.6% in Q3 2026, buying an estimated $115 and bringing the position to 168 shares worth $18.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2450.
SignatureFD first reported a position in KYMR in Q2 2021 and has held it in 16 quarters since. The position peaked at $19.1K in Q2 2026. 301 funds tracked by Wall St. Rank hold KYMR as of Q3 2026.
- SignatureFD held 168 shares of Kymera Therapeutics worth $18.7K as of Q3 2026.
- SignatureFD bought 1 Kymera Therapeutics share in Q3 2026, an estimated $115.
- Kymera Therapeutics made up ﹤0.01% of SignatureFD's portfolio in Q3 2026, its #2450 holding.
- SignatureFD first reported a position in Kymera Therapeutics in Q2 2021 and has held it in 16 quarters since.
- SignatureFD's Kymera Therapeutics position peaked at $19.1K in Q2 2026.
- 301 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q3 2026.
Based on SignatureFD's 13F filing for Q3 2026, filed 23 Oct 2026.